Hatch Aquaculture Accelerator

Ten early-stage aquaculture, aquatech and marine biotechnology companies from across the region are ready to start building toward investable, market-ready businesses.

Aviwell SAS, a deep‑tech animal nutrition company headquartered in Toulouse, today announced the successful completion of a €11 million Series A investment round, welcoming three new investors: Blue Revolution Fund (BRF), Blast.Club, and SWEN Capital Partners.

Biosort, best known for the development license project iFarm, has secured more than NOK 100 million from a strong group of aquaculture and technology investors to bring its individual-based lice control system to market.

The Blue Catalyst Challenge selected 10 early-stage ventures for its inaugural cohort. Hatch Blue and World Wide Fund for Nature (WWF) Singapore introduced the cohort with support from Singapore Economic Development Board (EDB).

Peptobiotics is a Singaporean biotechnology company whose first product is a recombinant antimicrobial peptide that replaces antibiotics in aquaculture.

Hatch Blue operates in investing, consulting and venture programs, drawing on decades of hands-on aquaculture expertise across major production markets. Its offerings include tailored investments, consulting and accelerator programs.

The form directs enquiries to the correct team.

Hatch Blue Holding Ltd's Privacy Policy explains how it handles personal data from website visits, program applications and engagement with investment teams, and describes privacy rights and legal protections.